Dr. Patrick Ojo, author of the book FREEDOM FOR PHARMACY, has signed with Creative Management Partners (CMP) agent Alan Morell for representation of his commercial rights across all platforms. The agreement covers literary works, including a planned sequel to FREEDOM FOR PHARMACY, broadcast opportunities, adaptation of his book into a docuseries, speaking engagements, endorsements, advisory roles with online courses, and licensing.
Dr. Ojo described the signing as a significant personal and professional milestone. "I am very excited to work with CMP on submission of my book, FREEDOM FOR PHARMACY, as they navigate the best Publisher for my Literary works and my career's commercial rights across CMP avenues of monetization," Ojo stated. The author's background includes a pharmacy degree from Long Island University, College of Pharmacy, Brooklyn, New York, and U.S. citizenship obtained in 1996. He has practiced pharmacy in various settings including community, hospital, and institutional pharmacies.
Agent Alan Morell emphasized the significance of the signing, particularly during the nation's 250th anniversary. "Dr. Patrick, in my view, is truly an American Hero, giving back, having worked with NYC Department of Homeless Services while graduating from Long Island University, College of Pharmacy, Brooklyn, New York, for his pharmacy degree AND also becoming a U.S. citizen in 1996," Morell said. He described Ojo's book as "groundbreaking reading" and a "must read" for audiences confused by today's pharmacy industry and big Pharma control.
The commercial representation agreement has implications for how pharmacy professionals and authors can navigate the business aspects of their expertise. Morell stated that through Dr. Patrick's book, "the reader can navigate the red tape, allowing them FREEDOM in this U.S. Medical Sector." CMP represents more than 700 clients across entertainment, sports, arts, medical, health and wellness, military, music, politics and business sectors, with Ojo joining their Medical Health Wellness Division which includes 248 doctors.
This development matters because it represents a convergence of healthcare expertise and commercial representation in an industry where pharmaceutical control and regulation significantly impact consumers. The partnership could amplify discussions about pharmacy practices and patient autonomy through various media platforms. For readers and industry professionals, the expanded reach of Ojo's message through potential adaptations and speaking engagements may provide greater access to alternative perspectives on navigating the U.S. pharmacy system. More information about Dr. Ojo's work can be found at www.liberatepharmacy1.com, while details about the representation agency are available at www.creativemanagementpartners.com.
